Division of Hematology & Medical Oncology

Medicine & Life Sciences

1. Iron 100%
2. Neoplasms 81%
3. Paraganglioma 57%
4. Interleukin-2 56%
5. Lymphokine-Activated Killer Cells 50%
6. Precursor Cell Lymphoblastic Leukemia-Lymphoma 48%
7. Pheochromocytoma 45%
8. metal transporting protein 1 45%
9. reolysin 38%
10. Genes 37%
11. Lectins 34%
12. Lymphocytes 34%
13. T-Lymphocytes 33%
14. Urinary Bladder Neoplasms 31%
15. Transferrin 29%
16. B-Cell Chronic Lymphocytic Leukemia 28%
17. RG7356 28%
18. Melanoma 28%
19. Pharmacokinetics 27%
20. Therapeutics 26%
21. Ligands 26%
22. Transferrin Receptors 26%
23. Prostatic Neoplasms 24%
24. Renal Cell Carcinoma 24%
25. Autophagy 24%
26. Breast Neoplasms 23%
27. Wheat Germ Agglutinins 23%
28. Circulating Neoplastic Cells 23%
29. Sorafenib 23%
30. Apoptosis 22%
31. MLN 8237 22%
32. gemcitabine 21%
33. Colorectal Neoplasms 21%
34. Vorinostat 20%
35. Survival 20%
36. Gene Expression 20%
37. lentil lectin 19%
38. Clinical Trials 19%
39. Cell Cycle 18%
40. Hemin 18%
41. Aurora Kinase A 18%
42. Protein Kinase C 18%
43. Hydroxychloroquine 18%
44. Tetradecanoylphorbol Acetate 17%
45. Tartrate-Resistant Acid Phosphatase 17%
46. Proteins 17%
47. Maximum Tolerated Dose 17%
48. Clinical Trials, Phase I 17%
49. Macrophages 17%
50. Safety 16%
51. Antigens 16%
52. Iron-Regulatory Proteins 16%
53. cdc Genes 15%
54. Castration 15%
55. Haptoglobins 15%
56. Cell Differentiation 15%
57. Flow Cytometry 14%
58. Neuroendocrine Tumors 14%
59. Ovarian Neoplasms 14%
60. Docetaxel 13%
61. Phorbol Esters 13%
62. Response Elements 13%
63. Interleukins 13%
64. Regulatory T-Lymphocytes 13%
65. Tamoxifen 13%
66. Lung 13%
67. Heterografts 13%
68. SGI 1776 13%
69. Cyclic AMP 13%
70. Epithelial-Mesenchymal Transition 12%
71. Immunity 12%
72. Mitogen Receptors 12%
73. AMG 479 12%
74. 5' Flanking Region 12%
75. Dendritic Cells 12%
76. Lymphokines 12%
77. Multiple Myeloma 12%
78. Messenger RNA 12%
79. Oncolytic Virotherapy 12%
80. Lucanthone 12%
81. 2-fluoroadenine 12%
82. pea lectin 11%
83. Antineoplastic Agents 11%
84. Growth 11%
85. Immunosuppression 11%
86. Pancreatic Neoplasms 11%
87. Deferoxamine 11%
88. Drug Therapy 11%
89. LDE225 11%
90. Interferons 11%
91. Vascular Endothelial Growth Factor A 11%
92. B-Cell Lymphoma 11%
93. Membranes 11%
94. denileukin diftitox 11%
95. DNA 11%
96. Lymphoma, Large B-Cell, Diffuse 11%
97. Aurora Kinases 11%
98. Alveolar Macrophages 11%
99. Heroin 11%
100. tiazofurin 11%